Louise Wang Zhiying Humphrey

Array ( [id] => 19257037 [patent_doc_number] => 12017066 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-25 [patent_title] => Modulation of extracellular vesicles with electrical stimulation [patent_app_type] => utility [patent_app_number] => 16/771323 [patent_app_country] => US [patent_app_date] => 2019-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 24325 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16771323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16686819 [patent_doc_number] => 20210069294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => SERUM RESPONSE FACTOR REGENERATES SENESCENT CELLS [patent_app_type] => utility [patent_app_number] => 16/959944 [patent_app_country] => US [patent_app_date] => 2018-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20543 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -51 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18886325 [patent_doc_number] => 11865081 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-09 [patent_title] => Oncolytic viral delivery of therapeutic polypeptides [patent_app_type] => utility [patent_app_number] => 16/958371 [patent_app_country] => US [patent_app_date] => 2018-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 57 [patent_no_of_words] => 38329 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14897545 [patent_doc_number] => 20190292538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-26 [patent_title] => SINGLE-CHAIN CIRCULAR RNA AND METHOD OF PRODUCING THE SAME [patent_app_type] => utility [patent_app_number] => 16/235656 [patent_app_country] => US [patent_app_date] => 2018-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5789 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16235656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14309573 [patent_doc_number] => 20190144490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-16 [patent_title] => COMPOSITIONS AND METHODS FOR SYNTHESIZING 5'-CAPPED RNAS [patent_app_type] => utility [patent_app_number] => 16/232435 [patent_app_country] => US [patent_app_date] => 2018-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18552 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16232435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15160825 [patent_doc_number] => 10485885 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-26 [patent_title] => Compositions and methods for delivery of agents [patent_app_type] => utility [patent_app_number] => 16/229509 [patent_app_country] => US [patent_app_date] => 2018-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 123 [patent_figures_cnt] => 159 [patent_no_of_words] => 104140 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16229509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17727677 [patent_doc_number] => 11384051 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-12 [patent_title] => Ionizable compounds and compositions and uses thereof [patent_app_type] => utility [patent_app_number] => 16/228054 [patent_app_country] => US [patent_app_date] => 2018-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 28996 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14498067 [patent_doc_number] => 20190192688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => Composition and Methods for Treatment of Ornithine Transcarbamylase Deficiency [patent_app_type] => utility [patent_app_number] => 16/228596 [patent_app_country] => US [patent_app_date] => 2018-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28739 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14439719 [patent_doc_number] => 20190177732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-13 [patent_title] => NUCLEIC ACID MOLECULES INDUCING RNA INTERFERENCE, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/220030 [patent_app_country] => US [patent_app_date] => 2018-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6807 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16220030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16305329 [patent_doc_number] => 10774107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-15 [patent_title] => DNA gridiron compositions and methods [patent_app_type] => utility [patent_app_number] => 16/202841 [patent_app_country] => US [patent_app_date] => 2018-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4001 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16202841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16703123 [patent_doc_number] => 10953036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-23 [patent_title] => Compositions and methods of modulating HIF-2A to improve muscle generation and repair [patent_app_type] => utility [patent_app_number] => 16/197023 [patent_app_country] => US [patent_app_date] => 2018-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 64 [patent_no_of_words] => 51177 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16197023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16326731 [patent_doc_number] => 20200297696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-24 [patent_title] => P38 INHIBITORS FOR THE TREATMENT OF FSHD [patent_app_type] => utility [patent_app_number] => 16/766030 [patent_app_country] => US [patent_app_date] => 2018-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10521 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16766030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14994329 [patent_doc_number] => 20190316122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => COMPOSITIONS COMPRISING EICOSAPENTAENOIC ACID AND MIPOMERSEN AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/189151 [patent_app_country] => US [patent_app_date] => 2018-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22669 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16189151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16604723 [patent_doc_number] => 10905707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-02 [patent_title] => Compositions and methods for the treatment of expanded repeat-associated disorders [patent_app_type] => utility [patent_app_number] => 16/185543 [patent_app_country] => US [patent_app_date] => 2018-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 25787 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16185543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16312663 [patent_doc_number] => 20200291401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-17 [patent_title] => METHODS OF RESCUING STOP CODONS VIA GENETIC REASSIGNMENT WITH ACE-TRNA [patent_app_type] => utility [patent_app_number] => 16/761205 [patent_app_country] => US [patent_app_date] => 2018-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30032 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16954880 [patent_doc_number] => 11058707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-13 [patent_title] => Methods for treating ischemic heart disease by targeting TRPV4 [patent_app_type] => utility [patent_app_number] => 16/178712 [patent_app_country] => US [patent_app_date] => 2018-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 40 [patent_no_of_words] => 6127 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16178712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16604783 [patent_doc_number] => 10905767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-02 [patent_title] => Oligonucleotide constructs and uses thereof [patent_app_type] => utility [patent_app_number] => 16/179786 [patent_app_country] => US [patent_app_date] => 2018-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 38 [patent_no_of_words] => 24033 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16179786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16199903 [patent_doc_number] => 10725058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-28 [patent_title] => Material and method for colorimetric detection of small-molecule targets [patent_app_type] => utility [patent_app_number] => 16/179336 [patent_app_country] => US [patent_app_date] => 2018-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 53 [patent_no_of_words] => 18222 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16179336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16901098 [patent_doc_number] => 20210180014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => METHOD OF ASSESSING ACTIVITY OF RECOMBINANT ANTIGEN RECEPTORS [patent_app_type] => utility [patent_app_number] => 16/760006 [patent_app_country] => US [patent_app_date] => 2018-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69067 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -152 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16376336 [patent_doc_number] => 20200325178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-15 [patent_title] => PEPTIDE NUCLEIC ACID MOLECULES FOR TREATMENT OF GRAM POSITIVE BACTERIAL INFECTION [patent_app_type] => utility [patent_app_number] => 16/760647 [patent_app_country] => US [patent_app_date] => 2018-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7569 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760647 [rel_patent_id] =>[rel_patent_doc_number] =>)